EZH2 often plays a role as a cancer promoter in gliomas, primarily regulating gene expression at the epigenetic level by catalyzing trimethylation of lysine 27 on histone H3 (H3K27me3) [19, 20]. This evidence concerns the gene EZH2 and central nervous system cancer.